Sandra Beaver Evolus, Inc. (EOLS) insider trading activity

Sandra Beaver is Chief Financial Officer of Evolus, Inc.. Currently has a direct ownership of 167,089 shares of EOLS, which is worth approximately $1.21 Million. The most recent transaction as insider was on May 13, 2025, when has been sold 6,494 shares (Common Stock) at a price of $10.02 per share, resulting in proceeds of $65,069. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 167K

0% 3M change

13.73% 12M change

Total Value Held $1.21 Million

Sandra Beaver Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 13 2025	SELL Open market or private sale	$65,069 $10.02 p/Share	6,494 Reduced 3.74%	167,089 Common Stock
Mar 18 2025	SELL Open market or private sale	$119,286 $13.26 p/Share	8,996 Reduced 4.93%	173,583 Common Stock
Mar 07 2025	BUY Grant, award, or other acquisition	-	35,663 Added 16.34%	182,579 Common Stock
Dec 23 2024	SELL Open market or private sale	$17,208 $10.85 p/Share	1,586 Reduced 1.07%	146,916 Common Stock
Sep 06 2024	SELL Open market or private sale	$49,074 $14.98 p/Share	3,276 Reduced 2.16%	148,502 Common Stock
May 10 2024	SELL Open market or private sale	$30,820 $12.72 p/Share	2,423 Reduced 1.57%	151,778 Common Stock
Mar 19 2024	SELL Open market or private sale	$78,954 $13.92 p/Share	5,672 Reduced 3.55%	154,201 Common Stock

Feb 22 2024	SELL Open market or private sale	$23,818 $13.08 p/Share	1,821 Reduced 1.13%	159,873 Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	13,115 Added 7.5%	161,694 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	35,211 Added 19.16%	148,579 Common Stock
Sep 06 2023	SELL Open market or private sale	$30,826 $9.7 p/Share	3,178 Reduced 2.73%	113,368 Common Stock
Aug 16 2023	SELL Open market or private sale	$22,706 $10.27 p/Share	2,211 Reduced 1.86%	116,546 Common Stock
Aug 14 2023	BUY Grant, award, or other acquisition	-	19,672 Added 14.21%	118,757 Common Stock
Jan 25 2023	BUY Grant, award, or other acquisition	-	62,642 Added 38.73%	99,085 Common Stock
Sep 05 2022	BUY Grant, award, or other acquisition	-	36,443 Added 50.0%	36,443 Common Stock

Also insider at

TNDM

TANDEM DIABETES CARE INC Healthcare

Director

Sandra Beaver

Chief Financial Officer

Newport Beach, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EOLS shares.

Notify only if

Value

Insider Trading

Get notified when an Evolus, Inc. insider buys or sells EOLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Evolus, Inc.

Track Activities on EOLS

Account